文献速递乳腺CT乳腺X线

对比增强乳腺CT与数字乳腺断层合成及数字乳腺X线摄影对可疑乳腺病灶显示清晰度的比较

Conspicuity of suspicious breast lesions on contrast enhanced breast CT compared to digital breast tomosynthesis and mammography.
PubMed 文献 · Br J Radiol · 2019-04-03

本研究纳入100例BI-RADS 4/5病灶女性,比较对比增强专用乳腺CT(CEbCT)、断层合成(DBT)和数字乳腺X线摄影(DM)对病灶的显示清晰度评分。恶性肿块在CEbCT上比DBT或DM更清晰;恶性钙化在三种 modality 上清晰度相当;良性钙化在DBT和DM上优于CEbCT;良性肿块在三种 modality 上无差异;清晰度评分与乳腺密度无关。

要点

  • 恶性肿块在CEbCT上的清晰度评分高于DBT和DM。
  • 恶性钙化在CEbCT、DBT和DM三种检查上清晰度相当。
  • 良性钙化在DBT和DM上比CEbCT显示更清晰。

核心结论

  • 恶性肿块在CEbCT上比DM或DBT更清晰;恶性微钙化在三种检查方式上清晰度相当;良性钙化在DM和DBT上比CEbCT显示更好;良性肿块在三种方式上无差异;良恶性病灶的清晰度评分均与乳腺密度无关。

研究设计与样本

  • 经IRB批准、符合HIPAA的研究,100例BI-RADS 4/5病灶女性在活检前接受CEbCT和/或DBT检查,由两名乳腺放射科医生独立判定每种检查方式的病灶清晰度评分。

关键影像表现/征象

  • 恶性肿块清晰度评分:CEbCT 9.7±0.5(n=25) vs DBT 6.8±3.1(n=15) vs DM 6.7±3.0(n=27),p<0.05。
  • 恶性钙化清晰度评分:CEbCT 8.7±0.8(n=18) vs DBT 8.5±0.6(n=15) vs DM 8.8±0.7(n=23),p=NS。
  • 良性肿块清晰度评分:CEbCT 6.6±4.1(n=22) vs DBT 6.4±3.8(n=17) vs DM 5.9±3.6(n=24),p=NS。
  • 良性钙化清晰度评分:DBT 8.5±1.0(n=17) vs DM 8.8±0.8(n=26),p=NS;CEbCT 4.0±2.9(n=25),p<0.001。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Compare conspicuity of suspicious breast lesions on contrast-enhanced dedicated breast CT (CEbCT), tomosynthesis (DBT) and digital mammography (DM).

METHODS: 100 females with BI-RADS 4/5 lesions underwent CEbCT and/or DBT prior to biopsy in this IRB approved, HIPAA compliant study. Two breast radiologists adjudicated lesion conspicuity scores (CS) for each modality independently. Data are shown as mean CS ±standard deviation. Two-sided t-test was used to determine significance between two modalities within each subgroup. Multiple comparisons were controlled by the false-discovery rate set to 5%.

RESULTS: 50% of studied lesions were biopsy-confirmed malignancies. Malignant masses were more conspicuous on CEbCT than on DBT or DM (9.7 ±0.5, n = 25; 6.8 ± 3.1, n = 15; 6.7 ± 3.0, n = 27; p < 0.05). Malignant calcifications were equally conspicuous on all three modalities (CEbCT 8.7 ± 0.8, n = 18; DBT 8.5 ± 0.6, n = 15; DM 8.8 ± 0.7, n = 23; p = NS). Benign masses were equally conspicuous on CEbCT (6.6 ± 4.1, n = 22); DBT (6.4 ± 3.8, n = 17); DM (5.9 ± 3.6, n = 24; p = NS). Benign calcifications CS were similar between DBT (8.5 ± 1.0, n = 17) and DM (8.8 ± 0.8, n = 26; p = NS) but less conspicuous on CEbCT (4.0 ± 2.9, n = 25, p < 0.001). 55 females were imaged with all modalities. Results paralleled the entire cohort. 69%(n = 62) of females imaged by CEbCT had dense breasts. Benign/malignant lesion CSs in dense/non-dense categories were 4.8 ± 3.7, n = 33, vs 6.0 ± 3.9, n = 14, p = 0.35; 9.2 ± 0.9, n = 29 vs. 9.4 ± 0.7, n = 14; p = 0.29, respectively.

CONCLUSION: Malignant masses are more conspicuous on CEbCT than DM or DBT. Malignant microcalcifications are equally conspicuous on all three modalities. Benign calcifications remain better visualized by DM and DBT than with CEbCT. We observed no differences in benign masses on all modalities. CS of both benign and malignant lesions were independent of breast density.

ADVANCES IN KNOWLEDGE: CEbCT is a promising diagnostic imaging modality for suspicious breast lesions.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Aminololama-Shakeri S, Abbey CK, López JE, et al. Conspicuity of suspicious breast lesions on contrast enhanced breast CT compared to digital breast tomosynthesis and mammography. Br J Radiol. 2019. PMID: 30810339. doi:10.1259/bjr.20181034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。